TransDigm Group (TDG) Sank To An 8-Month Low After Citron Research Report

TransDigm Group (TDG) steadily declined throughout the first half of the morning. The stock sold-off after Citron Research released a report that compared the company's business model to that of Valeant Pharmaceuticals International (VRX).

from RTT - Before the Bell http://ift.tt/2jgWFh6
via IFTTT